Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection China201680075852.4Filed on 2016-10-24
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection South Africa2018/02439Filed on 2016-10-24
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Vietnam1-2018-02233Filed on 2016-10-24
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Ukrainea 2018 05793Filed on 2016-10-24
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Peru000603-2018/DINFiled on 2016-10-24
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Eurasian Patent201891028Filed on 2016-10-24
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection BrazilBR112018008011-0Filed on 2016-10-24
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE Australia2016349392Filed on 2016-11-03
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE South Africa2018/02875Filed on 2016-11-03
NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE US Patent 11,236,152Filed on 2018-04-30